Media Coverage header image

Media Coverage

Advanced Search
  • 02282020
    Risk & Insurance Online

    A worker who is using the drug medicinally may fail a drug test and lose their job. But a recreational user could be making their workplace less safe for everyone if they come to work inebriated.[CR-LF][CR-LF]Enter workplace drug testing.[CR-LF][CR-LF]The rate of positive drug tests hit a 14 year high in 2018, according to a recent Los Angeles Times article. Of the 10 million tests processed by Quest Diagnostics, 4.4% tested positive for some type of drug.

  • 02262020
    Choosing Wisely

    Two years ago, the American Society for Clinical Pathology (ASCP) was presented with an opportunity to ratchet up adherence to one of its 30 recommendations — #21, which deals with evaluating adult patients with diabetes or hypertension for chronic kidney disease (CKD) through commonly used laboratory tests.[CR-LF][CR-LF]“What Choosing Wisely did was speed up the trajectory more than start the initiative,” said Lee Hilborne, MD, MPH, Past President and Chair of ASCP’s Appropriate Test Utilization Committee and Senior Medical Director for Quest Diagnostics, referring to the society’s partnership with the National Kidney Foundation to harmonize and simplify the testing protocol used to detect CKD.

  • 02262020
    PR Newswire - Online

    Quest Diagnostics Incorporated announced that it is scheduled to speak at the Barclays Global Healthcare Conference in Miami. Mark Guinan, Executive Vice President and CFO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, March 10, 2020 at 9:30 a.m. Eastern Time.

  • 02202020
    Forbes

    Democratic presidential candidates' calls for "Medicare for all" may seem like a threat to profits and innovation in the U.S. healthcare sector, but not all industry executives see it that way, even in the remote chance such a proposal is enacted. Some healthcare executives say giving the public the option of government coverage could actually be a net plus for the industry by adding more customers, particularly the estimated 44 million citizens who have no coverage. For companies like Quest Diagnostics, the largest provider of lab services, the answer is to roll up the industry to give it pricing power. "There are hundreds of laboratory companies, so our acquisition strategy is to consolidate the industry," CEO Stephen Rusckowski told Mergermarket. The company expects to spend an average of $250 million to $300 million a year on acquisitions.

  • 02192020
    360Dx

    While staffing shortages are one of main challenges facing the lab industry, some employees are seeing a benefit in the form of rising compensation. During Quest Diagnostics' Q4 earnings call last month, CFO Mark Guinan said that the company had seen "rising wage pressure" due to the tightening labor market. Quest President, Chairman, and CEO Steve Rusckowski noted that the firm was primarily seeing this pressure at what he called "the front end of our value chain," meaning positions like couriers and specimen processing where it competes for workers not only with other labs but also with employers outside the lab industry.

Show 5102550100 per page